← Back to Clinical Trials
Recruiting NCT07209293

NCT07209293 Oral Gastric Suctioning Effect on Transesophageal Echo

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07209293
Status Recruiting
Phase —
Sponsor Wake Forest University Health Sciences
Condition TEE Image Quality
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2025-10-22
Primary Completion 2027-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Transesophageal Echocardiography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2025-10-22 with a primary completion date of 2027-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

During heart surgery images of the heart are taken with transesophageal echocardiography. The images track how the heart is doing during surgery. It is normal practice to place an oral gastric tube in the stomach during heart surgery. The oral gastric tube is used to suction out stomach contents to avoid potential aspiration and avoid stomach acid build up. The purpose of this research study is to see if the images of the heart have better quality after your stomach has been emptied. This project hopes to help determine the best method to obtain the better quality images of the heart during cardiac surgery.

Eligibility Criteria

Inclusion Criteria: \- Transesophageal echocardiography assisted cardiac surgery Exclusion Criteria: * hiatal hernia * documented or suspected esophageal stricture * contraindications to a TEE

Contact & Investigator

Central Contact

Scott Coleman, DO

✉ Scott.Coleman@advocatehealth.org

📞 336-716-4498

Principal Investigator

Scott Coleman, DO

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT07209293 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying TEE Image Quality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07209293 currently recruiting?

Yes, NCT07209293 is actively recruiting participants. Contact the research team at Scott.Coleman@advocatehealth.org for enrollment information.

Where is the NCT07209293 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT07209293 clinical trial?

NCT07209293 is sponsored by Wake Forest University Health Sciences. The principal investigator is Scott Coleman, DO at Wake Forest University Health Sciences. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology